Balancing Favourable Drug-Likeness Against Respiratory and Renal Liabilities: An Integrated In Silico ADME–Toxicity Profile of a Novel 3-{[2-(Formimidoylamino)ethyl]sulfanyl}-6-(1-methoxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carbonyl fluoride. Editon Consortium Journal of Research in Medical and Health Sciences, [S. l.], v. 6, n. 1, p. 28–40, 2026. DOI: 10.51317/ecjrmhs.v6i1.758. Disponível em: https://system.rowadvocates.co.ke/index.php/ecjrmhs/article/view/758. Acesso em: 21 nov. 2026.